Janney Montgomery Scott LLC increased its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 18.6% in the 1st quarter, HoldingsChannel reports. The firm owned 1,043,922 shares of the real estate investment trust’s stock after acquiring an additional 164,055 shares during the period. Janney Montgomery Scott LLC’s holdings in Healthpeak Properties were worth $17,152,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in the business. WPG Advisers LLC boosted its holdings in shares of Healthpeak Properties by 270.2% during the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after buying an additional 1,197 shares in the last quarter. Advocate Investing Services LLC bought a new stake in shares of Healthpeak Properties in the 4th quarter valued at $26,000. Elyxium Wealth LLC acquired a new position in shares of Healthpeak Properties during the 4th quarter valued at $31,000. Clearstead Advisors LLC boosted its stake in Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after acquiring an additional 1,216 shares in the last quarter. Finally, CYBER HORNET ETFs LLC bought a new position in Healthpeak Properties during the second quarter worth $33,000. 93.57% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Healthpeak Properties
In other news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the sale, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.23% of the company’s stock.
Healthpeak Properties Stock Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.02. The business had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.Healthpeak Properties’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period last year, the company earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Research analysts expect that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.
Healthpeak Properties Announces Dividend
The firm also recently announced a monthly dividend, which was paid on Friday, June 26th. Investors of record on Monday, June 15th were paid a $0.1017 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a c) annualized dividend and a dividend yield of 5.7%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 381.25%.
Analysts Set New Price Targets
A number of equities research analysts have commented on the company. UBS Group raised their price objective on Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, May 13th. Raymond James Financial assumed coverage on Healthpeak Properties in a research report on Wednesday, June 17th. They set a “market perform” rating for the company. Weiss Ratings raised shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Morgan Stanley restated an “equal weight” rating and issued a $22.00 target price (up from $20.00) on shares of Healthpeak Properties in a research note on Thursday, June 11th. Finally, JPMorgan Chase & Co. increased their price objective on Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Three research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company’s stock. According to data from MarketBeat, Healthpeak Properties has an average rating of “Hold” and a consensus price target of $19.93.
Read Our Latest Stock Analysis on Healthpeak Properties
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
See Also
- Five stocks we like better than Healthpeak Properties
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
